Google’s AI Drug Startup Isomorphic Labs Nears $2 Billion Capital Raise
Isomorphic Labs, an AI-powered drug discovery company spun out of Alphabet Inc.’s Google DeepMind, is in advanced discussions…
Sleepless Americans Are Relying on Medicine and Pot to Doze Off
Nearly 13% of US adults are relying on medication, supplements or marijuana to help them sleep, a new…
OmniActive’s Capsimax may work as a GLP-1 ‘booster’
In a randomized clinical study recently published in the Academic Journal of Sports Science & Medicine, scientists from…
Tips to help choose over-the-counter medications safely and wisely – The Irish Times
Over-the-counter (OTC) medications help people cure some simple diseases easily and without seeing a doctor. Some OTC drugs…
BYHEALTH’s protein upgrade, MIRIQA’s immunity debut, Elevit in brand round-up
BYHEALTH Zhenzuan Protein Powder (BYHEALTH) Protein consumption is growing in China across different consumer groups and demand for…
No medicine supply issues for private hospitals despite Middle East war
PETALING JAYA: Private hospitals in the country are not experiencing any disruptions in the supply of medications despite…
GLP-1 RA generics have arrived. Could we buy semaglutide made for just $4?
Semaglutide is now generic. Just not in Australia. But in China, Brazil and Canada, generic drug makers are…
Fayetteville man pleads guilty in $3.1 million Medicare prescription drug scheme
Buffalo, N.Y. — A Fayetteville man pleaded guilty to federal charges Wednesday for his role in a $3.1…
New adrenaline nasal spray a 30-year first for Australia
The first nasal spray version of adrenaline is about to arrive in Australia, costing $194 for a two-pack. Branded…
Pura Collagen enters GLP-1 market with ‘pure’ hormone stimulating alternative
The two innovations expand the startup’s product line to seven, indicating the depth of consideration that goes into…
Singapore defies Trump’s tariffs as manufacturing drives growth
Singapore’s pharmaceutical and electronic manufacturers powered the economy in the final three months of 2025, pushing full-year growth…
GraphiteRx and Mark Cuban Cost Plus Drugs Deepen Partnership to Advance Availability of Lower-Cost Medications
Powering the Cost Plus Marketplace for Businesses Through Transparency, Innovation and Trust NASHVILLE, Tenn., December 4, 2025 (Newswire.com)…